Keeping Your Nose in Front: The Medicine Maker
January 4, 2021
Over the past few years, the pharmaceutical industry has become increasingly aware of the advantages nasal drug delivery could provide for their target product, patient population, and indication. In turn, this trend is fuelling the demand for experienced, specialist contractors to support the rise in inhalation formulation development.
In this article with The Medicine Maker, Dr. Charles Evans, Vice President of Pharmaceutical Development at MedPharm, explores how nasal drug delivery can help put the patient at the center of your development strategy and how this can help you keep your nose ahead of the competition.
Access the full article here.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm is experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established Centers of Excellence in the USA and the UK.